What is the catalog number for PRAS40 AKT1S1 Rabbit Monoclonal Antibody?

The catalog number for PRAS40 AKT1S1 Rabbit Monoclonal Antibody is orb548232.

What sizes are available for PRAS40 AKT1S1 Rabbit Monoclonal Antibody?

PRAS40 AKT1S1 Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is PRAS40 AKT1S1 Rabbit Monoclonal Antibody in stock?

PRAS40 AKT1S1 Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

PRAS40 AKT1S1 Rabbit Monoclonal Antibody

Product Specifications

Product Name Alternative

Proline-rich AKT1 substrate 1; 40 kDa proline-rich AKT substrate; AKT1S1; PRAS40

UniProt

Q96B36

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human PRAS40 Many growth factors and hormones induce the phosphoinositide 3-kinase signaling pathway, which results in the activation of downstream effector proteins such as the serine/threonine kinase Akt. One known Akt substrate is a 40 kDa, proline-rich protein (PRAS40) that binds to 14-3-3 protein. PRAS40 also binds mTOR to transduce Akt signals to the mTOR complex.

Target

Proline-rich AKT1 substrate 1

Clonality

Monoclonal

Clone

BCEJFX3

Conjugation

Unconjugated

Field of Research

Cell Biology, Neuroscience, Protein Biochemistry, Signal Transduction

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:500-2000 IP 1:20

Form

Liquid

Molecular Weight

58 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IP, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.